The Food and Drug Administration (FDA) approved Johnson & Johnson’s ketamine-derived nasal spray to help millions of U.S. patients suffering from severe depression. Spravato, approved as a ...

The FDA just approved this ketamine-derived nasal spray for depression treatment. by CNN/CNN Newsource. Wed, January 22nd 2025 at 2:20 AM (Janssen Pharmaceuticals, Inc./CNN/CNN Newsource) ...

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression. Here's what to know.

Esketamine, a form of ketamine taken as a nasal spray, has been approved for the treatment for moderate to severe treatment-resistant depression in Scotland but intravenous ketamine has not, though it ...

Today’s health headlines: ketamine nasal sprays offer a new option for people with treatment-resistant depression. Plus, how ...

Due in part to recent reports about Matthew Perry and Elon Musk, ketamine seems to be taking up more and more space in the conversation about substance abuse. But despite its recent spike in ...

"Ketamine has also been used to facilitate sexual assault." The approved medical product is used an injectable short-lasting anesthetic for people and animals as well as a nasal spray for ...

Major depressive disorder affects an estimated 8.3% of the adult population. And now there’s a new option for treatment: Spravato, a nasal spray that’s been shown to give rapid relief to ...

"Ketamine has also been used to facilitate sexual assault." The approved medical product is used an injectable short-lasting anesthetic for people and animals as well as a nasal spray for ...